Kairos Pharma and Bayer will evaluate ENV-105 in combination with [...]

The first patients have been dosed with MP0712, a DLL3-targeted [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

Orano has appointed Frederic Desdouits as chief executive officer of [...]

Molecular Partners AG, a clinical-stage biotech developing DARPin-based therapeutics, announced [...]

The UK is launching a major programme to convert used [...]